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Clinical background
C-type natriuretic peptide (CNP) is a 22-amino-acid pep-
tide produced mainly in the endothelium with potent car-
diac unloading and blood pressure lowering actions, but
minimal renal actions. Based on our previous knowledge,
we recently fused a 6 aa sequence from BNP to the C-ter-
minus and a 5 aa sequence from ANP to the N-terminus
of CNP. This novel hybrid peptide, CBA-NP, has cardiac
unloading actions and mild hypotensive effects similar to
CNP. Importantly however, the N and C terminus altera-
tions resulted in potent renal excretory actions. Here we
test the hypothesis that the 3 aa GSM15–17 in the disulfide-
ring mediate the vascular and hypotensive actions of CBA-
NP. We therefore mutated GSM 15–17 to REA15–17, which
we named ABC-NP and compared its in vivo and in vitro
actions to CBA-NP.
Methods
We determined the cardiorenal and humoral actions of
intravenous bolus administration of CBA-NP (n = 5) and
ABC-NP (n = 5) at 25 mg/kg in two separate groups of
normal anesthetized dogs. We also assessed the cGMP
response of both peptides in human aortic endothelial
cells (HAEC), human cardiac fibroblast (HCF) and iso-
lated canine glomeruli. * p < 0.05
Results
IV bolus administration of CBA-NP and ABC-NP resulted
in diuresis* and natriuresis*. There was a significant
decrease in mean arterial blood (MAP) pressure with CBA-
NP* but no change with ABC-NP. In addition, the reduc-
tion in pulmonary capillary wedge pressure (PCWP) and
right atrial pressure (RAP) was significantly greater with
CBA-NP as compared to ABC-NP. cGMP generation in
HAEC and HCF was minimal with ABC-NP and was sig-
nificantly higher with CBA-NP*. In contrast, cGMP gener-
ation was similar in isolated glomeruli between the two
peptides.
Conclusion
Our studies demonstrates that mutation of three amino
acid (aa) residues within the CNP ring of CBA-NP from
GSM  15–17 to REA alters the vascular but not the renal
excretory properties. Hence by this minimal mutation
within the ring of CBA-NP, we have designed a renal spe-
cific peptide ABC-NP resulting in new sequence specific
functional information which can be used to design organ
specific therapeutic peptides with unique properties tai-
lored for a specific disease state.
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